Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation

BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Armenian, Saro H, Xiao, Meisi, Berano Teh, Jennifer, Lee, Brandyn, Chang, Howard A, Mascarenhas, Kristen, Lee, Sean, Iukuridze, Alex, Xie, Jack J, Scott, Jessica M, Jones, Lee W, Lennie Wong, F, Forman, Stephen J, Nakamura, Ryotaro
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/
https://ncbi.nlm.nih.gov/pubmed/30951603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires